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SUMMARY: The objective of the present study was to evaluate the cardiovascular protective effect of 
Egyptian and European pumpkin seed oil (PSO) in hypercholesterolemic rats. Tocopherols, fatty acids (FAs) 
and unsaponifiable matter (UNSAP) were assessed in both oils. The results showed that α-tocopherol was 108 
and 273, g-tocopherol was 3.95 and 0 and d-tocopherol was 0 and 1.58 mg·100 g-1 oil of the Egyptian and 
European, respectively. GLC analysis of FAs revealed the presence of linoleic acid as the major fatty acid in 
both oils. Feeding a hypercholesterolemic diet produced a significant increase in plasma total cholesterol (T-Ch), 
 triglycerides (TGs), low density lipoprotein cholesterol, T-Ch/HDL-Ch, TGs/HDL-Ch and malondialdehyde 
and a significant reduction in high density lipoprotein cholesterol (HDL-Ch), vitamin E, and adiponectin. Rats 
fed on hypercholesterolemic diet with either oil showed a significant improvement in all biochemical parameters.
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RESUMEN: Ingredientes funcionales y efecto protector cardiovascular de aceites de semillas de calabaza. El obje-
tivo fue evaluar el efecto protector cardiovascular de aceites de semilla de calabaza (PSO) de variedades egipcia 
y europea en ratas con hipercolesterolemia. Se evaluó tocoferoles, ácidos grasos (FAs) y materia insaponificable 
(UNSAP) en ambos aceites. Los resultados mostraron valores de α-tocoferol de 108 y 273, g-tocoferol 3,95 y 0 y 
d-tocoferol de 0 y 1,58 mg·100 g-1 en las variedades egipcia y europea, respectivamente. El análisis por GLC de 
los ácidos grasos (FAS) mostró al linoleico como mayoritario en ambos aceites. La alimentación con una dieta 
hipercolesterolémica produjo en plasma un aumento significativo de colesterol total (T-Ch), triglicéridos (TG), 
colesterol en lipoproteínas de baja densidad, T-Ch/HDL-Ch, TGs/HDL- ch y malondialdehído y una reducción 
significativa en el colesterol de lipoproteínas de alta densidad (HDL-cH), vitamina E, y adiponectina. Las ratas 
alimentadas con una dieta hipercolesterolémica y con ambos aceites, mostraron mejoras significativas en todos 
los parámetros bioquímicos.
PALABRAS CLAVE: Adiponectina; Estrés oxidativo; Hipercolesterolemia; Perfil lipídico; PSO europeos y egipcios; 
Ratas
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1. INTRODUCTION
Hyperlipidemia is a predominant risk factor for 
cardiovascular diseases (CVD) which remains as 
one of the leading causes of death all over the world 
(Lim et al., 2012). It accounts for nearly 50% of all 
deaths in the Western developed world (Rich, 2006). 
Populations that consume a diet high in saturated 
fats and cholesterol tend to have higher incidence 
of coronary heart disease. The high levels of plasma 
LDL (low density lipoprotein) or other atherogenic 
lipoproteins are a prerequisite for most forms of ath-
erosclerosis (Carmena et al., 2004). Epidemiological 
studies have shown that, in European popula-
tions, a low concentration of plasma antioxidants 
increases the risk of developing coronary heart dis-
ease (Grey, 1986; Bruckdorfer, 1995). The World 
Health Organization recommends a reduction in 
dietary saturated fat and cholesterol intake to pre-
vent hypercholesterolemia and CVD. Elevated ratios 
of triglycerides to HDL-Ch and T-Ch to HDL-Ch 
reflect atherogenicity and are considered risk factors 
for CVD (da Luz et al., 2008). Growing evidence 
suggests that oxidative stress plays a major role in 
the initiation of atherosclerosis through stimulating 
inflammation and cytokine production (Fernández-
Robredo et al., 2008). A change in the endothelial 
function is one of the most important factors that 
participate in the progression of atherosclerosis 
and cardiovascular diseases (Thorand et al., 2006). 
Reactive oxygen species have been reported to induce 
endothelial dysfunction (Stewart-Lee et al., 1995). 
Many studies in animals and human have demon-
strated an association between the circulating cyto-
kine, adiponectin, endothelial function and coronary 
artery diseases (Kumada et al., 2003; Ouchi et al., 
2003; Shimabukuro et al., 2003; Tan et al., 2004; 
Ouchi et al., 2006). On the other hand, dyslipidemia 
and a pro-inflammatory and thrombogenic state 
(Saad and Gooren, 2009) are considered as compo-
nents of metabolic syndrome that may lead to CVD. 
Phytochemicals have received much interest 
in recent years because of their potential preven-
tion and curing of chronic diseases. Food rich in 
phytochemicals and nutrients such as carotenoids, 
tocopherols, unsaturated fatty acids, phytoster-
ols and phenolic compounds have been previously 
reported to have health benefits such as antioxi-
dant, anti-inflammatory and hypolipidemic effects 
(Geetha et al., 2004; Ansari et al., 2005; Prakash 
and Gupta, 2009). Intervention by antioxidants has 
been shown to improve endothelial dysfunction and 
reduce lipoprotein oxidation (Stewart- Lee et al., 
1995, Morel and Chisolm 1989) and thereby may 
prevent progression to atherosclerosis and CVD.
Phytosterols are proposed to have a wide spectrum 
of biological effects including anti-inflammatory, anti-
oxidative (de Jong et al., 2003; Berger et al., 2004) and 
cholesterol lowering activities (de Jong et al., 2003).
Mixed α, β, g and d- tocopherols have been 
shown to have better antioxidant and anti-inflam-
matory effects than α-tocopherol alone (Saldeen 
and Saldeen, 2005). 
Polyunsaturated fatty acids (PUFAs) have numer-
ous beneficial effects on CVD including improved 
blood lipid profile (Keys and Parlin, 1966) and anti-
inflammatory activity (Im, 2012).
The Pumpkin plant (Cucurbita sp.) of the 
Cucurbitaceae family is a native of Asia; however, it 
is now grown extensively in many of the temperate 
and warmer climates of the world. Species of pump-
kin available include Cucurbita pepo (most common), 
Cucurbita maxima, Cucurbita stilbo. (Phillips et al., 
2005) and Cucurbita moschata. Pumpkin seeds are 
rich in oil and the variability in the oil content is very 
high resulting from a broad genetic diversity. Twelve 
pumpkin cultivars (Cucurbita maxima D.), cultivated 
in Iowa, were shown to contain oil ranging from 10.9 
to 30.9% of high oxidative stability (Stevenson et al., 
2007). Pumpkin seed oil (PSO) is commonly used in 
folk medicine. It was shown in several countries that 
the incidence of hypertension, atherosclerosis, pros-
tatic hypertrophy and urinary bladder hyperplasia 
was reduced in people regularly consuming the seed 
oil. Also pumpkin seeds are used locally in Eritrea to 
treat tapeworm (Harvath, 1988; Schiebel-Schlosser 
and Friederich, 1998; Zuhair et al., 2000, Dreikorn, 
2002). PSO is rich in many antioxidants and beneficial 
nutritional supplements such as essential fatty acids 
(FAs), vitamins, squalene, carotenoids, tocopherols, 
phytoestrogenes, phytosterols, polyphenols, hydro-
carbon, triterpenoids and selenium (Zambo, 1988; 
Murkovic et al., 1996; Fruehwirth and Hermetter, 
2007; Gossell-Williams, 2008). 
It is hypothesized that the effect of PSO from 
different origins may differ due to changes in their 
content of bioactive ingredients that may be attrib-
uted to their broad genetic diversity and environ-
mental conditions, so it might be of interest to set 
a comparative study between them. So, the aim of 
the present research was to determine the functional 
ingredients including fatty acids, phytosterols and 
tocopherols in PSO in an Egyptain and European 
variety. The main aim was to evaluate the beneficial 
effects of such PSO on plasma lipid profiles, oxida-
tive stress and adiponectin concentration in rats fed 
a hypercholesterolemic diet.
2. MATERIALS AND METHODS
2.1. Materials
2.1.1. Plant materials
Egyptian pumpkin seeds (Cucurbita moschata, L. 
Family Curcubitaceae) were purchased from the local 
market, Cairo, Egypt. The plant was authenticated by 
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Dr/ Essam Mohamed Khalil, Researcher in Vegetable, 
Medicinal and Aromatic Plant Breeding Department, 
Horticulture Research Institute, Egypt. European 
PSO (Cucurbita pepo, L. Family Cucurbitaceae var. 
styria) was obtained from Graz, Austria.
2.1.2. Animals
Male white albino rats of body weight ranging 
from 80 to 100 g body weight were used in the present 
study. The animals were kept individually in stainless 
steel cages; water and food were given ad-libtium. 
The animal procedure was performed in accor-
dance with the Ethics Committee of the National 
Research Centre, Cairo, Egypt, and followed the rec-
ommendations of the National Institutes of Health 
Guide for Care and Use of Laboratory Animals 
(Publication No. 85-23, revised 1985).
2.2. Methods
2.2.1. Preparation of plant materials
Pumpkin seeds were dried in an air-circulated 
oven at 40 °C and reduced into powder.
2.2.2. Preparation of PSO
The dried powder of the seeds was placed in a 
Soxhlet and subjected to extraction using petroleum 
ether (40–60 °C) to prepare the oil. The solvent was 
completely removed by evaporation under reduced 
pressure at a temperature not exceeding 40 °C. 
2.2.3. Determination of tocopherols
Tocopherols (α, g and d) were determined in both 
Egyptain and European PSO using HPLC accord-
ing to the method of Amaral et al. (2005). 
HPLC conditions. An HPLC/Agilent model, 
Agilent 1100 G 1311A Quat pump, G1322A 
Degasser, G 1329A Autosampler, G 1330A Chiller, 
G 1316A column compartment, fluorescence detec-
tor PC and Chemstation software were used along 
with an SI (150 x 4.6 mm) column. The wave length 
of excitation was at 290 nm with emission at 330 nm. 
The mobile phase was a mixture of hexane and iso-
propanol (99:1, v/v), flow rate: 1 mL·min-1. The con-
centrations of (α, g and d) -tocopherols in the samples 
were obtained by comparing their peak areas with the 
peak area of standards in relation to concentration.
2.2.4. Assessment of FAs, hydrocarbon and 
phytosterol contents in Egyptian and European oils.
The UNSAP fraction and FA methyl esters of 
PSO were prepared according to A.O.A.C (2000) 
for the determination of FAs, hydrocarbons and 
 phytosterols using GLC.
The UNSAP fraction was analyzed by GLC 
adopting the following conditions: Column: 10% 
OV-101 packed column; Stationary phase: Chro-
mosorb W-HP; Detector temperature: 290  °C; 
Injector temperature, 28  °C; Carrier gas N2; flow-
rate 30  mL·min-1; air flow-rate: 300  mL·min-1; H2 
Flow-rate 30 mL·min-1; Detector FID; Chart speed: 
0.5  cm·min-1; Oven program: Initial temperature, 
70  °C; Final temperature, 270  °C; programmed 
4 °C·min-1 for 35 min at 270 °C, total time, 85 min. 
The identification of hydrocarbons and sterol con-
tents of the unsaponifiable matter was carried out by 
comparison of their retention times with co-injected 
authentic reference compounds. Quantification was 
based on peak area integration.
GLC analysis of the methyl ester was carried out 
according to the following conditions: Stationary 
phase: 10% diethylene glycosuccinate (DEGS) 
packed column; oven temperature, 170 °C; detector 
temperature, 300 °C; injector temperature, 250 °C; 
Carrier gas, N2; flow-rate, 30 mL·min
-1; air flow-rate, 
350 mL·min-1; H2 flow-rate, 350 mL·min
-1; detector, 
FID; Chart speed, 2 cm·min-1. Identification of the 
fatty acid methyl esters was carried out by the direct 
comparison of the retention times of each of the 
separated compounds with authentic samples of 
the fatty acid methyl esters analyzed under the same 
conditions. Quantification was based on peak area 
integration.
2.2.5. Preparation of dosage form
The oils were emulsified separately in water by 
gum acacia to adjust the dose carefully before given 
orally to rats. The vehicle was prepared to be given 
to the control rats by dissolving the same amount of 
gum acacia in water.
2.2.6. Preparation of diets
Balanced and hypercholesterolemic diets were 
prepared as shown in table (1). The hypercholes-
terolemic diet was designed as an intermediate 
between that reported by Matsumoto et al. (2004) 
and Mohammed et al. (2010). In the study by 
Matsumoto et al., the diet contained 20% beef tal-
low, 1.5% cholesterol and 1% sodium chlorate was 
used to induce hypercholesterolemia. In the study 
by Mohammed et al., the hypercholesterolemic 
diet contained 20% coconut oil, 1% cholesterol and 
0.25% cholic acid.
2.2.7. Design of the animal experiment
Thirty-six male rats were divided into six groups 
of  6 rats each. The first was the normal group 
where the rats received a balanced diet throughout 
the study period (one month), all other remain-
ing groups were fed a hypercholesterolemic diet. 
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One  served as a hypercholesterolemic control 
group, whereas the other four groups were fed 
a hypercholesterolemic diet along with an oral 
administration of  a daily dose of  either Egyptian 
or European PSO as 40 and 500 mg·kg-1 rat body 
weight throughout the study period. During the 
experiment, body weight and food intake were 
recorded once a week. At the end of  the study, total 
food intake, body weight gain and food efficiency 
ratio (Body weight gain/total food intake) were cal-
culated. Blood samples were collected from fasted 
animals for the determination of  total plasma 
lipids (Zollner and kirsch, 1962), T-Ch (Watson, 
1960), HDL-Ch (Burstein et al., 1970), low den-
sity lipoprotein cholesterol (LDL-Ch) (Gerard 
and Gerald, 1981) and TGs (Megraw et al., 1979). 
The T-Ch/HDL-Ch ratio and TGs/HDL-Ch ratio 
were calculated. Plasma malondialdehyde (MDA) 
was assessed as an indicator of  lipid peroxidation 
(Satoh, 1978). The plasma levels of  vitamin E were 
determined according to the method of  Desai and 
Machlin (1985). The plasma levels of  adiponec-
tin were estimated using the ELISA technique as 
a biomarker of  inflammation (Mouse/Rat HMW 
Adiponectin ELISA kit, Code No.: AKMAN-011, 
manufactured by Shibayagi Co., Ltd., Japan. The 
antibody is specific to rats), a method similar to 
that used in humans, according to Ryan (2003).
2.2.8. Statistical analysis
The results of the animal experiments were 
expressed as the Mean ± SEM and they were ana-
lyzed statistically using one-way analysis of variance 
ANOVA followed by the LSD test. In all cases p<0.05 
was used as the criterion of statistical significance.
3. RESULTS
3.1. FAs, hydrocarbon and phytosterol contents 
in PSO
Tables 2 and 3 show the FA and UNSAP in the 
oils, respectively. The results of the total FA analysis 
revealed that linoleic acid was the major unsaturated 
FA in the oils; it was present at 38.9 and 43.7% of the 
total FAs in European and Egyptian PSO, respec-
tively. Oleic acid was present in low amounts (3.5 
and 5.1 in European and Egyptian varieties, respec-
tively). Palmitic acid was the major saturated FA in 
the oils where it was present at 5.8% in European 
and 10.9% in the Egyptian type. Stearic acid was 
present in very low percentage in both oils. The GLC 
investigation of the UNSAP showed the presence of 
stigmasterol in a high percent (29.7% of UNSAP) in 
European PSO. Beta-Sitosterol was present as 3.4% 
in the Egyptian variety oil. Campesterol was present 
in both European and Egyptian varieties as 13.9 and 
2.2%, respectively. Total phytosterol was extremely 
high in the European seed oil 43.6% compared to 
the Egyptian oil (5.6 %). The major hydrocarbon 
was C20 in the European oil (6 %) and C22 in the 
Egyptian PSO (4.1%).
3.2. Tocopherol contents in PSO
Total tocopherol level in the European variety 
(275.08 mg·100  g-1) was higher than that in the 
Egyptian (111.95 mg·100  g-1). Alpha-tocopherol 
was present in the two oils, the European pumpkin 
seed oil showed a higher content (273.5 mg·100 g -1) 
than the Egyptain oil (108 mg·100  g-1). Gamma-
tocopherol was present only in the Egyptain variety 
as 3.95 mg·100 g-1 while d-tocopherol exists only in 
the European variety (1.58 mg·100 g-1).
3.3. Biological evaluation of PSO
Concerning the animal experiment, non- significant 
differences were observed between the different 
groups in final body weight, body weight gain and the 
food efficiency ratio (Table 4). The total food intake 
was significantly lower in the groups treated with PSO 
Table 2. Identified Fatty acids contents of pumpkin seed 
oils (as percentage of total fatty acids)
Fatty Acids European oil Egyptian oil
Palmitic Acid (C16:0) 5.80 10.90
Linoleic Acid (C18:2) 38.90 43.70
Oleic Acid (C18:1) 3.50 5.10
Stearic Acid (C18:0) 0.20 0.14
Total Saturated F.A 6.00 11.04
Total Unsaturated F.A 42.40 48.80
Table 1. Composition of different experimental diets 
(g 100 g–1)
Ingredients Balanced diet
Hypercholesterolemic 
diet
Casein 11.90* 11.90*
Fat
 Sheep tallow – 20.00
 Sun-flower oil 10.00 –
Maize starch 45.73 20.80
Sucrose 22.87 41.55
Cellulose 5.00 –
Salt mixture 3.50 3.50
Vitamin mixture 1.00 1.00
Cholesterol – 1.00
Sodium cholate – 0.25
Total 100 100
*11.9 g casein has been estimated to contain 10 g protein (AOAC, 
1995).
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in different doses compared to the normal and hyper-
cholesterolemic groups. 
The plasma levels of total lipids, T-Ch, LDL-Ch, 
TGs and the ratios of TGs/HDL-Ch and T-Ch/
HDL-Ch of the control hypercholesterolemic rats 
showed significant elevation by 171, 222, 749, 111, 
282 and 482%, respectively compared to the normal 
control. HDL-Ch in the control hypercholesterol-
emic rats was significantly reduced by 45% compared 
to the normal control group (Table 5). The control 
hypercholesterolemic rats showed an increase in oxi-
dative stress reflected by the significant reduction in 
plasma vitamin E and significant elevation in plasma 
MDA level by 52 and 112%, respectively, compared 
to the normal control. In addition, the plasma level 
of adiponectin was reduced significantly in the con-
trol hypercholesterolemic rats compared to the nor-
mal control by 8%. High and low doses of Egyptian 
PSO exerted a significant reduction in plasma lipid 
parameters compared to the hypercholesterolemic 
control as shown in total lipid, T-Ch, LDL-Ch, TGs 
and the ratios of TGs/HDL-Ch and T-Ch/HDL-Ch 
by 30, 33, 42, 41, 63 and 59%, respectively in the 
case of high dose, respectively and by 19, 17, 21, 
26, 43, and 36%, in the rats receiving the low dose. 
A  high European oil dose showed a significant 
reduction in plasma lipid parameters namely total 
lipids, T-Ch TGs, LDL-Ch, and the ratios of T-Ch/
HDL-Ch. and TGs/HDL-Ch (22, 36, 44, 45, 60 
and 65%, respectively) compared to the hypercho-
lesterolemic control. A low dose of European PSO 
also had similar but lower effects on the aforemen-
tioned parameters (Percentage reduction was 15, 18, 
31, 23, 42 and 51, respectively). Plasma HDL-Ch 
was significantly elevated on administration of 
either Egyptian or European PSO compared to the 
 hypercholesterolemic control.
Plasma vitamin E was significantly elevated while 
plasma adiponectin was significantly increased in all 
rats given the oil compared to the hypercholester-
olemic control. The percentage increase in vitamin 
E and adiponectin in the groups given a high dose 
of either Egyptain or European oil compared to 
the hypercholesterolemic group was 72%, and 9%, 
respectively. The percentage increase in adiponec-
tin was 7 and 8% in the case of rats given the low 
dose of PSO of Egyptian and European oils com-
pared to the control hypercholesterolemic rats. The 
% increase in vitamin E was 41 and 39% in Egyptian 
and European low doses, respectively.
The Plasma MDA level was reduced signifi-
cantly in the rats given either Egyptian (high and 
low doses) or European oils (high and low doses) 
by 35, 28, 34 and 26%, respectively compared to 
the control hypercholesterolemic rats. The Egyptian 
and European oil high doses matched each other in 
more than one parameter namely HDL-Ch, T-Ch, 
LDL-Ch, vitamin E, MDA, adiponectin and the 
Table 3. GLC analysis of unsaponifiable matter 
of pumpkin seed oils (as percentages of total 
unsaponifiable matter)
Hydrocarbons 
and sterols European PSO Egyptian PSO
C15 0.05 –
C16 0.09 0.01
C18 0.15 0.15
C19 3.86 3.11
C20 6.08 –
C21 0.69 –
C22 4.25 4.11
C23 – –
C24 0.45 –
C25 3.23 –
C26 3.29 –
C27 4.44 –
C28 3.87 –
Total Identified 
Hydrocarbons
30.45 7.38
Campesterol 13.90 2.20
Stigmasterol 29.70 –
Beta-sitosterol – 3.40
Total Identified 
phytosterols
43.60 5.60
Table 4. Nutritional parameters of different experimental groups (mean±SEM)
Parameters
Normal 
control
n=6
Hypercholesterolemic 
control
n=6
Egptian high 
dose oil
n=6
Egyptian low 
dose oil
n=6
European high 
dose oil
n=6
European low 
dose oil
n=6
Initial body weight (g) 93.00a±3.76 92.70a±3.34 93.17a±3.94 92.70a±3.16 93.17a±2.33 92.70a±2.42
Final body weight (g) 176.50a±9.64 177.00a±7.39 164.50a±9.36 175.00a±6.37 164.17a±6.51 174.17a±3.94
Body weight gain (g) 83.50a±9.44 84.33a±7.52 71.33a±6.48 82.33a±3.67 71.00a±6.54 81.50a±6.27
Total food intake (g) 376.5a±6.22 372.33a±4.11 334.83c±13.03 341.50bc±6.86 337.00bc±9.35 360.00ab±6.47
Food intake g/day 13.45a±0.22 13.30a±0.147 11.96c±0.47 12.20bc±0.245 12.04bc±0.33 12.86ab±0.23
Food efficiency ratio (g) 0.22a±0.03 0.23a±0.02 0.21a±0.02 0.24a±0.01 0.21a±0.02 0.23a±0.01
In each row the same letter means non-significant difference while different letters mean significant differences at 0.05 probability.
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ratios of T-Ch/HDL-Ch and TGs/HDL-Ch. Also, 
the Egyptian and European oil low doses showed 
the same phenomenon for the aforementioned 
parameters except for TGs/HDL-Ch.
It is worthy to mention that the plasma adiponec-
tin of the groups given PSOs showed non-significant 
difference compared to the normal control while all 
the other plasma parameters, although improved, 
were still significantly different from the normal rats. 
4. DISCUSSION
The present study was postulated to assess the 
usefulness of PSO in alleviating the risks of CVD 
that may be associated with a hypercholesterolemic 
diet. The tocopherol, phytosterol, and the FA con-
tents of both the Egyptian and European PSO were 
determined. The beneficial effects of low and high 
doses of such oils towards plasma lipid profile, oxi-
dative stress and adiponectin (an inflammatory bio-
marker) in the rats fed a hypercholesterolemic diet 
were monitored.
The hypercholesterolemic diet used in the pres-
ent study produced dyslipidemia reflected by a 
significant elevation of plasma total lipids, total 
cholesterol, triglycerides and LDL-cholesterol with 
a significant reduction in HDL-Ch. The significant 
increase in TGs/ HDL-Ch, T-Ch/HDL-Ch, and the 
significant reduction in the plasma levels of HDL-
cholesterol in hypercholesterolemic rats in the pres-
ent study were in agreement with those reported 
previously (Yang et al., 2006). The elevation in the 
ratios of TGs/HDL-Ch and T-Ch/HDL-Ch are 
considered as atherogenic factors that may lead 
to atherosclerosis (Yang et al., 2006; da Luz et al., 
2008). The administration of PSO with different 
doses produced a significant reduction in these 
ratios compared with the hypercholesterolemic 
control rats but still significantly higher than nor-
mal. This anti-atherogenic property of PSO may be 
mediated by the high concentration of linoleic acid 
which exists in PSO as demonstrated by Makni et al. 
(2008). Epidemiological studies have shown that the 
probability of coronary artery disease decreases lin-
early with the high content of the unsaturated fatty 
acids in the food stuff  (Key, 1970). A reduction in 
LDL-Ch can reduce cardiovascular events by up to 
60% (Law et al., 2003). Dietary components that 
directly lower LDL-Ch are important for reducing 
CVD risk. From the present study and from pre-
vious literature PSO was shown to contain phyto-
setrol, unsaturated FAs, phenolic compounds and 
Table 5. Plasma parameters of different experimental groups (mean±SEM)
Parameters Normal control
Hypercholesterolemic 
control
Egyptian high 
dose oil
Egyptian low 
dose oil
European high 
dose oil
European low 
dose oil
Total lipids (mg dL−1)
% Change
373.48f±7.52 1013.78a±11.25
171
710.67e±14.79
−30
825.32c±8.90
−19
792.42d±12.42
−22
858.32b±11.94
−15
Total- Ch (mg dL−1 )
% Change
90.00d±1.32 289.42a±3.82
222
193.25c±5.23
−33
239.08b±4.17
−17
185.25c±3.64
−36
236.17b±2.44
−18
HDL- Ch (mg dL−1)
% Change
45.46a±0.77 25.22d±0.81
45
40.55b±0.78
61
32.76c±1.12
30
39.87b±1.04
58
35.56c±1.64
41
LDL- Ch (mg dL−1)
% Change
26.69d±1.26 226.59a±3.48
749
130.34c±5.73
−42
178.51b±4.55
−21
124.45c±4.36
−45
174.71b±3.27
−23
TGs (mg dL−1)
% Change
89.24f±1.79 188.08a±2.65
111
111.81d±1.15
−41
139.07b±2.87
−26
104.66e±1.62
−44
129.45c±1.41
−31
Total -Ch/ HDL-Ch  
(mg dL−1)
% Change
1.98d±0.03 11.54a±0.41
482
4.78c±0.20
−59
7.35b±0.32
−36
4.67c±0.19
−60
6.72b±0.34
−42
TGS / HDL-Ch  
(mg dL−1)
% Change
1.97e±0.05 7.50a±0.31
282
2.76d±0.07
−63
4.28b±0.20
−43
2.64d±0.09
−65
3.68c±0.19
−51
MDA(nmol mL−1)
% Change
7.74d±0.38 16.42a±0.47
112
10.68c±0.44
−35
11.86bc±0.78
−28
10.80c±0.40
−34
12.19b±0.19
−26
Vitamin E (mg dL−1)
% Change
1.07a±0.05 0.51d±0.03
−52
0.88b±0.03
72
0.72c±0.01
41
0.88b±0.02
72
0.71c±0.01
39
Adiponectin (ng mL−1)
% Change
5060.00a±62.01 4643.33b±45.28
−8
5038.33a±70.10
9
4973.33a±40.63
7
5041.67a±23.00
9
5010.00a±44.34
8
In each row the same letter means non-significant difference while different letters mean significant differences at 0.05 probability.
% change in the column of hypercholesterolemic control was calculated by comparing the hypercholesterolemic control with the 
normal control.
% change in the last 4 columns was calculated by comparing the hypercholesterolemic groups given PSO with the hypercholesterolemic 
control.
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carotenoids which collectively possess lipid lowering 
and antioxidant and anti-inflammatory effects (Van 
Hoed et al., 2002; Matus et al., 1993).
 Hypercholesterolemia induces oxidative stress 
by causing a reduction in the antioxidant enzymatic 
defense potential of tissues and the generation of 
oxygen free radicals. As a result of these metabolic 
events, peroxidation reactions are accelerated, lead-
ing to cellular injury and atherosclerosis (Gokkusu 
and Mostafazadeh, 2003). The elevation in oxida-
tive stress in hypercholesterolemic control rats in the 
current study was reflected by a reduction in plasma 
vitamin E as an indicator of antioxidant status and 
the elevation of MDA as an indicator of lipid per-
oxidation. The oral administration of both PSOs 
prevented the elevation of oxidative stress through 
amelioration of the previously mentioned parame-
ters. These results were explained in the light of PSO 
antioxidant properties (Zuhair et al., 2000) that may 
be related to the presence of phytosterols and α, g 
and d tocopherols that could serve as antioxidants.
 Hypercholesterolemia was accompanied by a 
reduction in adiponectin levels in the control hyper-
cholesterolemic rats indicating inflammation in adi-
pose tissue in the present study. Administration of 
any of the studied oils significantly elevated adipo-
nectin levels in the rats fed the hypercholesterolemic 
diet indicating an anti-inflammatory activity of 
PSO. Adiponectin is a novel cytokine secreted from 
adipose tissue (Chandran et al., 2003) and is nor-
mally present in human plasma at concentrations 
up to 30 µg/ml but is markedly lower in association 
with obesity-linked diseases including coronary 
artery disease and type 2 diabetes (Hotta et al., 
2000). Clinical observations have demonstrated that 
hypoadiponectinemia is closely related to endothe-
lial dysfunction in peripheral arteries (Shimabukuro 
et al., 2003; Tan et al., 2004) and that plasma total 
adiponectin concentrations are inversely related to 
the risk of myocardial infarction (Pischon et al., 
2004). These results suggest that PSO might improve 
endothelial dysfunction which is manifested by ele-
vating adiponectin and thereby protect from the 
occurrence of coronary artery diseases.
The improvement in plasma lipid profile, oxida-
tive stress and adiponectin levels in the rats fed the 
hypercholesterolemic diet and given both PSOs may 
be attributed to the presence of tocopherols, phy-
tosterols and unsaturated FAs determined in the 
present study. PSO has been previously shown to 
contain high levels of tocopherols (Van Hoed et al., 
2009) which render it antioxidant activity and thus 
may be capable of reducing lipid peroxidation and 
act as an antioxidant. PSO is rich in n-6 PUFA that 
has been proven to have an anti-atherogenic effect 
in rats maintained on a high fat diet for 5 months as 
reported by Kim et al. (2012). 
Phytosterols have been shown to decrease LDL- 
Ch in hypercholesterolemic subjects by suppressing 
cholesterol absorption (Vanstone et al., 2002; 
Alhassan et al., 2006). The intake of plant sterols 
has been shown to confer a healthier lipid profile 
and  ameliorate cardiovascular disease risk factors 
(Ziv et al., 2009). 
Phytosterol concentration was reported to be 
24.9 mg·100 g-1 in pumpkin seed (Ryan et al., 2007). 
It was reported by Ryan et al. (2007) that the level 
of β-sitosterol was 24.9 mg·100 g-1, and stigmasterol 
was 8.4 mg·100 g-1 in PSO while campesterol was not 
detected. Philips et al. (2005) indicated that pumpkin 
seed kernel contains β-sitosterol as 13.1 mg·100 g-1 
and that PSO contains 241 mg·100 g-1 (>90%) of 
other sterols. In the present study, the predominant 
phytosterol in Egyptian PSO was β-sitosterol while 
in the European oil, it was stigmasterol. 
The four dominant fatty acids in pumpkin seeds 
are palmitic (13.3%), stearic (8%), oleic (29%) and 
linoleic (47%). These four fatty acids make up 
98±0.13% of the total amount of  fatty acids; others 
being found at levels well below 0.5%. The oil con-
tains an appreciable amount of  unsaturated fatty 
acids (78 %) and was found to be a rich source of 
linoleic acid (Murkovic et al., 1996 a; El-Adawey 
and Taha, 2001; Younis et al., 2000; Rayan et al., 
2007). The fatty acids found in PSOs in the pres-
ent study were palmitic, stearic, oleic and linoleic. 
In the current study both PSOs contain high per-
centages of  unsaturated FA represented by lin-
oleic acid. Saturated FAs were very low compared 
to unsaturated FAs, the main saturated FA was 
palmitic acid. These results agree with the results 
obtained by Bravi et al. (2006). Previous studies 
have shown that in the varieties used for oil produc-
tion, palmitic occurs in the range of  10.3–11.7%, 
stearic 4.1–5.4%, oleic 30.5–40.8% and linoleic 
42.1–51.5% (Wenzel, 1987). In the present study, 
palmitic % of  the Egyptain variety was similar to 
the abovementioned study. The Egyptian PSO has 
linoleic acid as 43.7 %, however stearic and oleic 
showed much lower percentages than the aforemen-
tioned study. This may be due to the broad genetic 
diversity of  PSO. 
The total percentage of unsaturated FA was 
81.6–82.7% in the PSO of C. pepo, a German vari-
ety (Cerny et al., 1971; Wenzel, 1987). These previ-
ous % were higher than that in the present study. 
Younis et al. (2000) reported that the level of linoleic 
acid was 43–50% while it was 36.6–60.8% in other 
European varieties, (Murkovic et al., 1996a, 1996b). 
In the present study the level of linoleic acid in both 
Egyptian and European varieties falls within the lat-
ter range.
It was reported that the consumption of  soy-
bean oil containing 50% linoleic acid signifi-
cantly reduced the mortality rate due to coronary 
artery  disease (Younis et al., 2000). This may 
reflect the beneficial effect of  linoleic acid in PSO 
towards CVD.
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Both PSO used in the present study contain oleic 
acid, which previously showed benefits on early 
events in atherosclerosis (Carluccio et al., 1999) 
because it decreased lipoprotein susceptibility to 
oxidation (Tsimikas et al., 1999). Oleic acid may 
prevent endothelium activation either by inhib-
iting the expression of  adhesion molecules or by 
affecting nitric oxide production (Christon, 2003). 
The presence of  carotenoids in PSO (Younis et al., 
2000) may share in the cardio-protective effect as 
reported previously (Melendez-Martinez et al., 
2004). 
The reduction in oxidative stress, elevation of 
adiponectin and improvement in plasma lipid 
profile due to the oral administration of  both oils 
may also be ascribed to the presence of  phenolic 
compounds (Fruehwirth and Hermetter, 2007) 
that have been reported to have antioxidant, anti-
inflammatory and hypocholesterolemic activity 
(Löliger, 1991). 
The tocopherol content in PSO may also con-
tribute to the beneﬁts observed, since tocopherol 
supplementation provides cardiovascular protec-
tion attributed to antioxidant mechanisms and 
peroxyl radical scavengering activity (Yamauchi, 
2007). Knekt et al., (1994) and Kushi et al., (1996) 
demonstrated that the tocopherol content in food is 
inversely associated with mortality from cardiovas-
cular disease. 
It was reported previously that the g-tocoph-
erol content in PSO, which is about 5–10 times as 
much as that of α-tocopherol, varies over a broad 
range  (41–620 mg·kg-1 dry pumpkin seeds). β- and 
d-tocopherol were found at low levels (Murkovic 
et al., 1996b). In the present study α-tocopherol 
was higther than g- tocopherol in the Egyptain vari-
ety and higher than d-tocopherol in the European 
variety.
In the current study, despite the difference in 
the contents of FAs, phytosterols and tocopherols 
of the Egyptian and European oils, they showed 
significant comparable improvements in plasma 
lipid profile, antioxidant status, lipid peroxidation 
parameters and adiponectin levels compared to the 
hypercholesterolemic rat group. It was noticed that 
a high dose of Egyptian and European PSO pro-
duced a much better effect than the low one.
It can be concluded that the Egyptian and 
European PSO produced an improvement in plasma 
lipid profile, adiponectin and antioxidant status. 
Both PSO produced reduction in plasma T-Ch/
HDL-Ch and TG/HDL-Ch that may afford pro-
tection from atherosclerosis and CVD. The cardio- 
protective effect of PSO may be due to the presence 
of a high percentage of USFA, phytosterols and 
tocopherols determined in the present study in addi-
tion to the phenolic compounds and carotenoids 
described previously.
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